Swedish Agency for Health Technology Assessment and Assessment of Social Services

Swedish Agency for Health Technology Assessment and Assessment of Social Services
Name	Swedish Agency for Health Technology Assessment and Assessment of Social Services
Formation	1987
Headquarters	Stockholm
Region served	Sweden

Swedish Agency for Health Technology Assessment and Assessment of Social Services is a Swedish governmental body responsible for systematic evaluation of medical devices, pharmaceuticals, healthcare interventions and social care services to inform policy and practice. The agency produces evidence syntheses used by Region Västra Götaland, Stockholm County Council, Uppsala County and other regional authorities, interacting with institutions such as Karolinska Institutet, Umeå University, Lund University and Sahlgrenska University Hospital. Its outputs have informed decisions by bodies like Swedish National Board of Health and Welfare, Swedish Association of Local Authorities and Regions, European Medicines Agency, World Health Organization and Organisation for Economic Co-operation and Development.

History

The agency traces origins to initiatives in the late 20th century that paralleled work at National Institute for Health and Care Excellence, Canadian Agency for Drugs and Technologies in Health, Cochrane Collaboration and Agency for Healthcare Research and Quality. Early collaborations involved Karolinska Institutet, Uppsala University and Göteborg University researchers, and it grew amid reforms influenced by reports from Swedish Ministry of Health and Social Affairs and commissions connected to Riksdag debates. Over time it expanded mandates to cover social services and to coordinate with entities such as European Observatory on Health Systems and Policies, Nordic Council of Ministers and Scandinavian Journal of Public Health contributors. Notable moments include cross-border projects with National Health Service (England), methodological exchanges with Helsinki University Hospital and participation in multinational studies with Institut Pasteur, Robert Koch Institute and Karolinska University Hospital.

Organisation and Governance

The agency is headquartered in Stockholm and organized into units mirroring structures found at Finnish Medicines Agency, Danish Health Authority and Norwegian Directorate of Health. Governance includes oversight by the Swedish Ministry of Health and Social Affairs and advisory links to the Riksdag health committees, with stakeholder engagement from Swedish Association of Local Authorities and Regions and professional bodies such as Swedish Medical Association and Swedish Association of Social Worker. Leadership has interfaced with researchers from Uppsala Clinical Research Center, Lundbeck Foundation partners, and expert panels drawing on clinicians from Karolinska University Hospital, Linköping University Hospital and ethicists associated with Uppsala University. Financial accountability aligns with practices at National Audit Office (Sweden) and procurement rules compatible with European Commission directives.

Mandate and Functions

Statutory responsibilities encompass producing systematic reviews, health technology assessments and social services evaluations analogous to mandates at National Institute for Health and Care Excellence, Canadian Agency for Drugs and Technologies in Health and Institute for Quality and Efficiency in Health Care. The agency advises Swedish National Board of Health and Welfare, informs commissioning by Region Skåne and supports policy development at the Swedish Ministry of Health and Social Affairs. It covers technologies ranging from magnetic resonance imaging systems to vaccination programmes and from housing adaptation schemes to psychiatric service models, interacting with regulatory actors including European Medicines Agency, Swedish Medical Products Agency and Swedish Data Protection Authority when assessments touch on clinical trials, medical ethics or privacy. Outputs aim to support clinicians at institutions like Sahlgrenska University Hospital, administrators at Region Västra Götaland and advocacy groups such as Swedish Patients' organisation.

Methodology and Assessment Processes

Methodological frameworks draw on standards from Cochrane Collaboration, GRADE Working Group, PRISMA reporting guidance and techniques used by Agency for Healthcare Research and Quality. Processes include systematic literature searches of databases curated by Uppsala University Library, critical appraisal using tools aligned with CONSORT and STROBE checklists, and economic modelling comparable to approaches at Health Technology Assessment International and National Institute for Health and Care Excellence. The agency convenes multidisciplinary expert panels with clinicians from Karolinska Institutet, statisticians from Stockholm University, health economists formerly at Lund University, and social care specialists from Malmö University. Ethical review considerations reference rulings of the Swedish Ethical Review Authority and legal frameworks like decisions by the European Court of Human Rights when assessments intersect with rights under Social Services Act (Sweden) deliberations.

Major Reports and Impact

Major assessments have addressed hip replacement technologies, antidepressant use in youth, screening programmes, robot-assisted surgery, opioid stewardship, and models for eldercare and child protection services. Reports have influenced procurement by Region Stockholm, clinical guidelines at Swedish National Board of Health and Welfare, and reimbursement discussions involving the Dental and Pharmaceutical Benefits Agency (Sweden). The agency’s analyses have been cited in scientific outlets such as The Lancet, BMJ, Annals of Internal Medicine and in policy documents from World Health Organization and OECD Health Directorate, shaping practice at hospitals including Karolinska University Hospital and networks like European Reference Networks.

Collaboration and International Engagement

The agency participates in networks including Health Technology Assessment International, European Network for Health Technology Assessment, Nordic Cochrane Centre collaborations and bilateral exchanges with National Institute for Health and Care Excellence, Canadian Agency for Drugs and Technologies in Health and Australian Government Department of Health. It partners with academic institutions such as Karolinska Institutet, Uppsala University, Lund University and research organizations like Institut Pasteur, Robert Koch Institute and London School of Hygiene & Tropical Medicine. Engagement extends to multilateral fora including World Health Organization, Organisation for Economic Co-operation and Development and European Commission panels, contributing to harmonization of methods across European Union member states and Nordic health systems.

Category:Health technology assessment Category:Social care in Sweden